Programs
The Ketamine Training Center
the ketamine training center overview
Ketamine Assisted Psychotherapy (KAP) is a novel, breakthrough approach to the awakened mind and the healing of trauma and depression. The Ketamine Training Center is the premier organization in the field having provided training to over 800 practitioners in our 6-day residential retreat events.
The heart of the Ketamine Research Foundation’s work to establish Ketamine Assisted Psychotherapy (KAP) in the world as unique psychotherapy is the training of practitioners interested in establishing KAP practices. Beginning in early 2018, The Ketamine Training Center began its series of intensive 4-day (now 6 day) programs introducing practitioners to the didactics of KAP and the experience of ketamine in the two formats we utilize in KAP—sublingual lozenges and intramuscular injections.
With more programs planned for 2023 in various locations across the world, we will have trained over 800 physicians, therapists, nurses, naturopathic physicians, and other disciplines bringing together individuals to function as teams and clinics.
Ketamine is a Schedule 3 medicine and requires medical administration and supervision, therefore, team building is essential for KAP. Establishing ourselves as the KAP niche within the ever-widening mass of IV anesthesiology clinics, it is our fundamental position that those administering a powerful psychoactive substance must personally experience and understand its attributes and potentialities. As KAP offers the potential of a deep and heartful practice to its practitioners with truly extraordinary results and experiences, the gratification of being a KAP practitioner becomes evident to those in the trainings. We follow up the trainings with additional zoom sessions to each group and encourage their membership in the Ketamine Psychotherapy Associates as an ongoing supportive, consultative, and referral resource.
We are pleased with the continued and expanding interest in the trainings and their success has enabled financial contributions to the Ketamine Research Foundations and its programs. We are in the process of planning for 2023/2024 and with our “Training of Trainers” group are able to expand our offerings.
The Ketamine Training Center is recognized as the premier and essential training for ketamine practitioners devoted to psychedelic psychotherapy using the only presently FDA approved psychedelic medicine. We are proud to be at the forefront of training in this incredible work.
We have arranged with PeerPoint Medical Education Institute to provide a certificate of training for each participant after the conclusion of each training. This will provide 30 AMA Category I credits which are applicable to both medical practitioners and therapists—acceptable to licensing boards in over 40 states, (please confirm with your State Licensing Board if you have a questions).
We are looking forward to being with you in what have been profound learning, experiential and connecting events that continue to move KAP forward and support our developing practices.
FACULTY
Learn More
Phil Wolfson MD was Principal Investigator for the MAPS sponsored Phase 2, FDA approved 18-person study of MDMA Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine Assisted Psychotherapy. Phil’s book The Ketamine Papers has been published by MAPS and is the seminal work in the burgeoning ketamine arena. Phil is a sixties activist, psychiatrist/psychotherapist, writer, practicing Buddhist and psychonaut who has lived in the Bay Area for 38 years. He is the author of Noe – A Father/Son Song of Love, Life, Illness and Death (2011, North Atlantic Books). In the 1980s, he participated in clinical research with MDMA (Ecstasy). He has been awarded five patents for unique herbal medicines. He is a journalist and author of numerous articles on politics, transformation, psychedelics, consciousness and spirit, and was a founding member of the Heffter Research Institute. Phil has taught in the graduate psychology programs at JFK University, CIIS and the UCSF School of Medicine Department of Psychiatry.
Learn More
Julane Andries is a practicing psychotherapist in Marin County, Ca. She worked in acute care medicine before becoming a marriage family therapist. She is an investigator in the MAPS Phase 3 study using MDMA assisted psychotherapy for severe PTSD in San Francisco. She was the principle co-therapist for the MAPS sponsored, Phase 2 MDMA assisted psychotherapy study for individuals suffering from anxiety with life-threatening illness. She has been a pioneer in the development of Ketamine Assisted Psychotherapy
Her work is unique and is creative to the psychotherapy process using this medicine. She, along with others on their team, treats patients with treatment resistant depression, first line depression, anxiety and PTSD, as well as those seeking transformation.
She and Dr. Wolfson have founded a non-profit, Ketamine Research Foundation, whose mission is to provide training for practitioners, collect data to track outcomes with Ketamine therapy, starting a new protocol for using KAP for those diagnosed with a life threatening illness, and those in palliative and hospice care, research in lactating women and ketamine for post-partum depression, ketamine for PMS and other projects. Julane is also co-founder of the Ketamine Training Center and helps lead trainings across the country teaching practitioners in the skills used in KAP.
The first journal article for outcomes in KAP using data from our practice and 2 other associated practices has just been accepted for publication: Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.
Julane has a passionate interest in understanding trauma, its impact on the mind and body, and in stimulating the healing process.
Co-Founder and Co-Therapist of KAP
Leader in the Ketamine Training Center
Ketamine Research Foundation – Board officer
Research in outcomes for KAP
Phase 2 and Phase 3 –Invesstigator/Co-therapist FDA trial for MDMA Assisted Psychotherapy for Severe PTSD and Life –Threatening Illness
Monica Winsor is an independent consultant to individuals and social beneficiary organizations with a focus on integrative health, consciousness and poverty alleviation. In 2005 she co-founded Inspired Philanthropy Group (IPG), providing strategic philanthropic advice, innovative fundraising, and cause-related marketing to individuals, foundations, and non-profit organizations. Prior to IPG Monica co-created the 6 Villages campaign for FXB International and was a founding vice- chair of the Women Moving Millions campaign.
Monica is Vice Chair of The Synergos Institute, a global organization that convenes diverse stakeholders to solve complex issues around poverty and inequity, and is co-chair of Synergos’ Global Philanthropy Circle. She is Chair of Grammy winning singer Angelique Kidjo’s Batonga Foundation and a board member of The Garrison Institute, (former Chair), The Terracycle Foundation, The William H. Donner Foundation and Donner Canadian Foundation.
A graduate of Brown University and yoga teacher and yoga therapist for many years, Monica uses the principles of yoga as a basis for work with individuals and organizations. She recently completed the Ketamine Assisted Psychotherapy (KAP) training and lives and practices in New York City.
Learn More
Learn More
Learn More
Learn More
Learn More
Learn More
Learn More
Learn More
I would do it all over again:
Be the harbor and set the sail,
Loose the breeze and harness the gale,
Cherish the harvest of what I have been.
Better the summit to scale.
Better the summit to be.
– Toni Morrison
Testimonials
“Thank you so much for a truly wonderful workshop. You both impart such compassionate wisdom and maturity to the multiple aspects of psychedelic medicine, from biochemistry to ethics. Apart from it being an amazingly enjoyable experience, I can’t remember the last time I learned so much on so many levels in just 4 days.”David Dansky, MDPast Participant
“I saw into the heart of my soul and connected with the universe and its inhabitants as one. I came away knowing I could release myself and others from trauma and suffering and contribute to a healing of the world”
Anonymous
“With all my experience of psychedelic medicines, ketamine’s release from my body and the welcome absence of my ego enabled me to know myself as the pure energy I truly am. I returned to a sense of liberation from my usual formats and obsessions. This interruption of my ordinary mind liberated me to begin anew, to original being.”
Anonymous